510(k) Report

510(k) · Cleared

Cleared

cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System

K153544510(k) Dual TrackCleared Jul 25, 2016227-day reviewClass II21 CFR 866.3980

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Iquum, Inc. · OCC Respiratory Virus Panel Nucleic Acid Assay System

Cleared on Jul 25, 2016 as substantially equivalent to K111387 (Iquum, Inc., 2011) and 5 other predicates after a 227-day review. Its family tree reaches back 6 generations to 2008. 4 later devices descend from it.

Decided
Jul 25, 2016
Review
227 days
Class
Class II
Product code
OCC
Recalls
None
Predicates
6

Its longest line of descent runs back 6 generations to DEN070013 (2008). 14 ancestors in all, the oldest DEN060008 (2006). 4 later devices descend from it, 1 citing it directly.

  1. Root · 6 generations backDEN070013 ID-Tag Respiratory Viral PanelLuminex Molecular Diagnostics, Inc. · 2008
  2. 5 generations backK081483 Xtag Respiratory Viral PanelLuminex Molecular Diagnostics, Inc. · 2008 · Recalled
  3. 4 generations backK091667 Xtag Respiratory Viral Panel, Models I019A0110, I019C011, I019D0112…Luminex Molecular Diagnostics, Inc. · 2009 · Recalled
  4. 3 generations backK100148 Simplexa Influenza a H1N1 (2009) Model MOL2500Focus Diagnostics, Inc. · 2010
  5. 2 generations backK103766 Xpert Flu, Genexpert DX Systems, Genexpert Infinity System…Cepheid · 2011 · Recalled
  6. 1 generation backK111387 Liat (TM) Influenza a / B Assay, Liat (TM) AnalyzerIquum, Inc. · 2011 · Recalled
  7. This deviceK153544 cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas…Iquum, Inc. · 2016
  8. Descendant · cites it directly · 3 of its ownK200065 cobas Influenza A/B Nucleic acid test for use on the cobas Liat…Roche Molecular Systems, Inc. · 2020
  9. Descendant · 2 generations on · 1 of its ownK210234 cobas Influenza A/B & RSV Nucleic acid test for use on the cobas…Roche Molecular Systems, Inc. · 2021
  10. Descendant · 2 generations on · 0 of its ownK260047 cobas Strep A Nucleic acid test for use on the cobas Liat System…Roche Molecular Systems, Inc. · 2026
  11. Descendant · 3 generations on · 0 of its ownK213822 cobas Influenza A/B & RSV nucleic acid test for use on the cobas…Roche Molecular Systems, Inc. · 2022

Most influential descendants

Showing 4 of 4 · See all
  • K200065cobas Influenza A/B Nucleic acid test for use on the cobas Liat System, cobas Influenza…Roche Molecular Systems, Inc. · 2020 · cites it directly3descendants
  • K210234cobas Influenza A/B & RSV Nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc. · 2021 · 2 generations on1descendant
  • K260047cobas Strep A Nucleic acid test for use on the cobas Liat System (07341911190); cobas…Roche Molecular Systems, Inc. · 2026 · 2 generations on0descendants
  • K213822cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc. · 2022 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6DEN070013ID-Tag Respiratory Viral PanelLuminex Molecular Diagnostics, Inc.2008—
−5K081483Xtag Respiratory Viral PanelLuminex Molecular Diagnostics, Inc.20081
−4K091667Xtag Respiratory Viral Panel, Models I019A0110, I019C011, I019D0112…Luminex Molecular Diagnostics, Inc.20091
−3K100148Simplexa Influenza a H1N1 (2009) Model MOL2500Focus Diagnostics, Inc.2010—
−2K103766Xpert Flu, Genexpert DX Systems, Genexpert Infinity System, Genexpert System…Cepheid20111
−1K111387Liat (TM) Influenza a / B Assay, Liat (TM) AnalyzerIquum, Inc.20114
0 (this device)K153544cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat SystemIquum, Inc.2016—
+1K200065cobas Influenza A/B Nucleic acid test for use on the cobas Liat System, cobas…Roche Molecular Systems, Inc.2020—
+2K210234cobas Influenza A/B & RSV Nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc.2021—
+2K260047cobas Strep A Nucleic acid test for use on the cobas Liat System…Roche Molecular Systems, Inc.2026—
+3K213822cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc.2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200610
200830
200910
201110
201310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
202110
202210
202610
FIG. 1 — Lineage of K153544, 2008–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OCC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OCC device

  1. #1 K262747 ID NOW Influenza A & B 2; ID NOW RSV; ID NOW…score 15.2 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (6)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K111387Liat (TM) Influenza a / B Assay, Liat (TM) Analyzer
Summary page 9
…sse ProFlu+™ Roche cobas® Influenza A/B Nucleic Acid Test for Use on the cobas® Liat System 2. Predicate 510(k) number(s): K073029, K081030, K092500, K110968, K132129 K111387 5-5 ® cobas Liat Influenza A/B & RSV Assay Dual Submissio…
Iquum, Inc.20114
*K073029Proflu+ Assay
Summary page 9
…: 1. Predicate device name(s): Hologic Prodesse ProFlu+™ Roche cobas® Influenza A/B Nucleic Acid Test for Use on the cobas® Liat System 2. Predicate 510(k) number(s): K073029, K081030, K092500, K110968, K132129 K111387 5-5 ® cobas…
Prodesse, Inc.2008—
*K081030Modification to Proflu+ Assay
Summary page 9
…dicate device name(s): Hologic Prodesse ProFlu+™ Roche cobas® Influenza A/B Nucleic Acid Test for Use on the cobas® Liat System 2. Predicate 510(k) number(s): K073029, K081030, K092500, K110968, K132129 K111387 5-5 ® cobas Liat Infl…
Prodesse, Inc.2008—
*K092500Modification to Proflu+ Assay
Summary page 9
…vice name(s): Hologic Prodesse ProFlu+™ Roche cobas® Influenza A/B Nucleic Acid Test for Use on the cobas® Liat System 2. Predicate 510(k) number(s): K073029, K081030, K092500, K110968, K132129 K111387 5-5 ® cobas Liat Influenza A/B…
Prodesse, Inc.2009—
*K110968Proflu+ Assay
Summary page 9
…(s): Hologic Prodesse ProFlu+™ Roche cobas® Influenza A/B Nucleic Acid Test for Use on the cobas® Liat System 2. Predicate 510(k) number(s): K073029, K081030, K092500, K110968, K132129 K111387 5-5 ® cobas Liat Influenza A/B & RSV As…
Gen-Probe Prodesse, Inc.2011—
*K132129Prodesse Proflu+ Assay
Summary page 9
…gic Prodesse ProFlu+™ Roche cobas® Influenza A/B Nucleic Acid Test for Use on the cobas® Liat System 2. Predicate 510(k) number(s): K073029, K081030, K092500, K110968, K132129 K111387 5-5 ® cobas Liat Influenza A/B & RSV Assay Dual…
Gen-Probe Prodesse, Inc.2013—

Also cleared against K111387: 2 other devices →

What descends from it? (4)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K200065cobas Influenza A/B Nucleic acid test for use on the cobas Liat System, cobas Influenza…Roche Molecular Systems, Inc.20203

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 4 companies; a new generation was cleared every 11 months on median.
  • 4 of the 14 ancestors have a recall of any class.
  • Of its descendants, K200065 (Roche Molecular Systems, Inc., 2020) has gone furthest, with 3 descendants of its own.
  • 2 other devices also cite its predicate K111387.

How does its category compare?

All OCC devices

OCC Respiratory Virus Panel Nucleic Acid Assay System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · OCC

1in 2024

2008: 42009: 62010: 22011: 92012: 62013: 62014: 42015: 82016: 72017: 102018: 42019: 52020: 22021: 12022: 12023: 22024: 12026 (partial year): 3
2007high 10 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OCC

31in 2019

2008: 28 days median2009: 24 days median2011: 82 days median2012: 125 days median2013: 79 days median2014: 94 days median2015: 85 days median2016: 92 days median2017: 136 days median2018: 134 days median2019: 31 days median2026 (partial year): 130 days median
2007high 136 (2017) · low 24 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OCC

1in 2024

2014: 12018: 12019: 12024: 1
2007high 1 (2014) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OCC

2in 2025

2011: 22012: 12014: 522015: 12016: 362017: 12018: 12019: 22020: 172021: 6862022: 22023: 12024: 32025: 2
2007high 686 (2021) · low 0 (2007)2025

MAUDE reports naming product code OCC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
200842800
200962400
20102—00
201198202
2012612501
201367900
2014494152
201588501
2016792036
20171013601
2018413411
201953112
20202—017
20211—0686
20221—02
20232—01
20241—13
20250—02
202631300—

What is it indicated for?

The cobas® Influenza A/B & RSV Nucleic Acid Test for Use on the cobas® Liat System (cobas® Liat Influenza A/B & RSV) is an automated multiplex real-time RT-PCR assay for the rapid in vitro qualitative detection and discrimination of influenza A virus, influenza B virus and respiratory syncytial virus (RSV) RNA in nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection in conjunction with clinical and epidemiological…

Read the full statement (318 words)

The cobas® Influenza A/B & RSV Nucleic Acid Test for Use on the cobas® Liat System (cobas® Liat Influenza A/B & RSV) is an automated multiplex real-time RT-PCR assay for the rapid in vitro qualitative detection and discrimination of influenza A virus, influenza B virus and respiratory syncytial virus (RSV) RNA in nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection in conjunction with clinical and epidemiological risk factors. The test is intended for use as an aid in the diagnosis and differentiation of influenza A, influenza B, and RSV in humans and is not intended to detect influenza C.

Negative results do not preclude influenza virus or RSV infection and should not be used as the sole basis for treatment or other patient management decisions. Conversely, positive results do not rule-out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.

Performance characteristics for influenza A were established during the 2013-2014 and the 2014-2015 influenza seasons when influenza A/H3 and A/H1N1 pandemic were the predominant influenza A viruses in circulation. When other influenza A viruses are emerging, performance characteristics may vary.

If infection with a novel influenza A virus is suspected based on current clinical and epidemiological screening criteria recommended by public health authorities, specimens should be collected with appropriate infection control precautions for novel virulent Influenza viruses and sent to state or local health department for testing. Viral culture should not be attempted in these cases unless a BSL 3+ facility is available to receive and culture specimens.

The cobas® Influenza A/B & RSV Quality Control Kit contains External Controls for use with the cobas® Liat Influenza A/B & RSV assay. External Controls are run during the Add cobas® Liat Influenza A/B & RSV Tube Lot procedure. Additional External Controls should be tested in accordance with local, state, federal and/or accrediting organization requirements as applicable.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K153544: cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K153544

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026